ImmunID's new biomarker links reduced immune diversity with cancer | Longevity science | Scoop.it
ImmunID's latest biomarker is named divpenia®, which underpins a new concept for the scientific community for reduced immune diversity of T & B lymphocytes potentially correlated to immune deficiencies.

Via Brian Shields